Ten years ago, a group of individuals with type 1 diabetes (T1D) took matters into their own hands and developed a do-it-yourself (DIY) approach to their treatment. They created software that would automate the process of monitoring and controlling blood glucose levels using insulin pumps and constant glucose monitors. The DIY community has since grown, with approximately 30,000 people now using open-source technology for automated insulin delivery. Despite the emergence of commercial systems, many advocates believe that the DIY community still has a role to play in pushing the technology forward. The recent approval of an open-source algorithm-based system by the US Food and Drug Administration could pave the way for more accessible DIY options.
https://www.nature.com/articles/d41586-023-02648-9